Wassif S. Wassif

706 total citations
17 papers, 550 citations indexed

About

Wassif S. Wassif is a scholar working on Epidemiology, Molecular Biology and Nephrology. According to data from OpenAlex, Wassif S. Wassif has authored 17 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in Wassif S. Wassif's work include Parathyroid Disorders and Treatments (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Eating Disorders and Behaviors (3 papers). Wassif S. Wassif is often cited by papers focused on Parathyroid Disorders and Treatments (5 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Eating Disorders and Behaviors (3 papers). Wassif S. Wassif collaborates with scholars based in United Kingdom, Sweden and United States. Wassif S. Wassif's co-authors include Roy Sherwood, Philip M. Bath, H. Abraha, Richard Butterworth, John Garthwaite, Declan M. McLoughlin, Gerald Russell, Bin Tean Teh, Filip Farnebo and E Spargo and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Wassif S. Wassif

16 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wassif S. Wassif United Kingdom	10	208	195	133	129	87	17	550
J. Hensen Germany	18	204 1.0×	172 0.9×	71 0.5×	37 0.3×	81 0.9×	61	1.2k
A. Paracchi Italy	22	113 0.5×	106 0.5×	61 0.5×	45 0.3×	56 0.6×	36	1.4k
Jyh‐Ming Jimmy Juang Taiwan	22	443 2.1×	107 0.5×	88 0.7×	27 0.2×	66 0.8×	85	1.2k
Ilda S. Kunii Brazil	16	128 0.6×	78 0.4×	21 0.2×	185 1.4×	128 1.5×	55	671
C. Páramo Spain	12	72 0.3×	90 0.5×	45 0.3×	49 0.4×	63 0.7×	25	863
M. Yanagisawa Japan	11	146 0.7×	228 1.2×	80 0.6×	25 0.2×	33 0.4×	28	623
Lúcio Vilar Brazil	21	115 0.6×	179 0.9×	46 0.3×	16 0.1×	58 0.7×	80	1.6k
Ayşe Kubat Üzüm Türkiye	13	79 0.4×	63 0.3×	25 0.2×	47 0.4×	33 0.4×	59	474
Leonie T. van Hulsteijn Netherlands	14	47 0.2×	149 0.8×	92 0.7×	43 0.3×	32 0.4×	29	840
Anne-Lise Lecoq France	11	72 0.3×	42 0.2×	122 0.9×	107 0.8×	32 0.4×	25	445

Countries citing papers authored by Wassif S. Wassif

Since Specialization

Citations

This map shows the geographic impact of Wassif S. Wassif's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wassif S. Wassif with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wassif S. Wassif more than expected).

Fields of papers citing papers by Wassif S. Wassif

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wassif S. Wassif. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wassif S. Wassif. The network helps show where Wassif S. Wassif may publish in the future.

Co-authorship network of co-authors of Wassif S. Wassif

This figure shows the co-authorship network connecting the top 25 collaborators of Wassif S. Wassif. A scholar is included among the top collaborators of Wassif S. Wassif based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wassif S. Wassif. Wassif S. Wassif is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Wassif, Wassif S., et al.. (2022). Haematological and biochemical pathology markers for a predictive model for ITU admission and death from COVID‐19: A retrospective study. SHILAP Revista de lepidopterología. 3(3). 660–668. 1 indexed citations

2.

Boot, Christopher, et al.. (2021). A UK national audit of the laboratory investigation of phaeochromocytoma and paraganglioma. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 59(1). 65–75. 2 indexed citations

3.

Wassif, Wassif S., Declan M. McLoughlin, Royce P Vincent, et al.. (2011). Steroid metabolism and excretion in severe anorexia nervosa: effects of refeeding. American Journal of Clinical Nutrition. 93(5). 911–917. 18 indexed citations

4.

MacQueen, Hilary, Dawn Sadler, Sandeep Daya, et al.. (2007). Deleterious effects of a cafeteria diet on the livers of nonobese rats. Nutrition Research. 27(1). 38–47. 15 indexed citations

5.

Conroy, Simon, Wassif S. Wassif, John E. Cooper, David R. Jenkins, & Constantine A. Stratakis. (2004). Atrial myxoma: a cardiocutaneous syndrome. Hospital Medicine. 65(1). 56–57. 3 indexed citations

6.

Conroy, Simon, Sophie Moulias, & Wassif S. Wassif. (2003). Primary hyperparathyroidism in the older person. Age and Ageing. 32(6). 571–578. 15 indexed citations

7.

Conroy, Simon & Wassif S. Wassif. (2003). Hyperparathyroidism – pitfalls in management. British Journal of Biomedical Science. 60(1). 35–36. 2 indexed citations

8.

Wassif, Wassif S., et al.. (2001). CASE REPORT: Celiac Disease in Patients with Variegate Porphyria. Digestive Diseases and Sciences. 46(7). 1506–1508. 5 indexed citations

9.

McLoughlin, Declan M., Wassif S. Wassif, John Morton, et al.. (2000). Metabolic abnormalities associated with skeletal myopathy in severe anorexia nervosa. Nutrition. 16(3). 192–196. 30 indexed citations

10.

Wassif, Wassif S., Filip Farnebo, Bin Tean Teh, et al.. (1999). Genetic studies of a family with hereditary hyperparathyroidism–jaw tumour syndrome. Clinical Endocrinology. 50(2). 191–196. 48 indexed citations

11.

Farnebo, Filip, Soili Kytölä, Bin Tean Teh, et al.. (1999). Alternative Genetic Pathways in Parathyroid Tumorigenesis*. The Journal of Clinical Endocrinology & Metabolism. 84(10). 3775–3780. 71 indexed citations

12.

McLoughlin, Declan M., E Spargo, Wassif S. Wassif, et al.. (1998). Structural and functional changes in skeletal muscle in anorexia nervosa. Acta Neuropathologica. 95(6). 632–540. 85 indexed citations

13.

Farnebo, Filip, Bin Tean Teh, Cornelia Dotzenrath, et al.. (1997). Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Human Genetics. 99(3). 342–349. 58 indexed citations

14.

Abraha, H., Richard Butterworth, Philip M. Bath, et al.. (1997). Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(4). 366–370. 75 indexed citations

15.

Abraha, H., Richard Butterworth, Philip M. Bath, et al.. (1997). Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(5). 546–550. 115 indexed citations

16.

Preedy, Victor R., et al.. (1996). Experimental D-penicillamine-induced myopathy. Biochemical Society Transactions. 24(2). 266S–266S. 3 indexed citations

17.

Why, Howard, et al.. (1995). Antioxidant Status in Hypertension and Effects of Angiotensin Converting Enzyme Inhibition. Biochemical Society Transactions. 23(2). 224S–224S. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact